Adverse events following immunisation (AEFIs) will be recorded on Co-Win and meticulously monitored, senior officials said. The government is expected to come up with an advisory for doctors and the general public on identification, investigation and management of AEFIs in the next two days. The advisory will outline specific symptoms that need to be investigated and managed if reported after vaccination.
“Covid vaccines are allowed under emergency licensure and, therefore, they cannot be sold at chemists,” an official told TOI.
“It is important to administer them in a proper set-up and follow the guidelines during immunisation. Besides, all these vaccination centres, including the ones at workplaces, are linked with AEFI management centres to ensure identification and investigation of any adverse reaction,” the official said.
The Centre has allowed those above 18 to receive vaccines from May 1, opening options for states, hospital chains and corporates to vaccinate those eligible. Shots will continue to be free for health and frontline staff and those over 45 under the Centre’s programme.